Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children

Pediatrics

Volumn 117, Issue 1, 2006, Pages

  Kheirandish, Leila ^a   Goldbart, Aviv D ^a   Gozal, David ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoids; Budesonide; Glucocorticoid receptors; Leukotriene receptors; Lymphoid hyperplasia; Montelukast; Sleep apnea; Sleep disordered breathing; Tonsillectomy and adenoidectomy; Tonsils

Indexed keywords

BUDESONIDE; GLUCOCORTICOID RECEPTOR; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; STEROID; ACETIC ACID DERIVATIVE; GLUCOCORTICOID; QUINOLINE DERIVATIVE;

ADENOIDECTOMY; ALLERGIC RHINITIS; ARTERIAL OXYGEN SATURATION; ARTICLE; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; EPISTAXIS; FEMALE; HUMAN; LYMPHOID HYPERPLASIA; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULSE OXIMETRY; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SLEEP TIME; TONSILLECTOMY; TREATMENT OUTCOME; DRUG COMBINATION; INTRANASAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION;

ACETATES; ADENOIDECTOMY; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; BUDESONIDE; CHILD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; POLYSOMNOGRAPHY; QUINOLINES; SLEEP APNEA SYNDROMES; TONSILLECTOMY;

EID: 33644846268     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0795     Document Type: Article

References (51)

1. Kaditis AG, Finder J, Alexopoulos EI, et al. Sleep-disordered breathing in 3,680 Greek children. Pediatr Pulmonol. 2004;37:499-509
2. Frank Y, Kravath RE, Pollak CP, Weitzman ED. Obstructive sleep apnea and its therapy: clinical and polysomnographic manifestations. Pediatrics. 1983;71:737-742
3. Tal A, Leiberman A, Margulis G, Sofer S. Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment. Pediatr Pulmonol. 1988;4:139-143
4. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and children. J Pediatr. 1982;100:31-40
5. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med. 1998;157:1098-1103
6. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics. 1998;102:616-620
7. Guilleminault C, Winkle R, Korobkin R, Simmons B. Children and nocturnal snoring-evaluation of the effects of sleep related respiratory resistive load and daytime functioning. Eur J Pediatr. 1982;139:165-171
8. Owens J, Opipari L, Nobile C, Spirito A. Sleep and daytime behavioral sleep disorders. Pediatrics. 1998;102:1178-1184
9. O'Brien LM, Gozal D. Behavioral and neurocognitive implications of snoring and obstructive sleep apnea in children: facts and theory. Paediatr Respir Rev. 2002;3:3-9
10. Arens R, McDonough JM, Corbin AM, et al. Upper airway size analysis by magnetic resonance imaging of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2003;167:65-70
11. Rosen CL, Larkin EK, Kirchner HL, et al. Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity. J Pediatr. 2003;142:383-389
12. Schechter MS; Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2002;109(4). Available at: www.pediatrics.org/cgi/content/full/109/4/e69
13. Lipton AJ, Gozal D. Treatment of obstructive sleep apnea in children: do we really know how? Sleep Med Rev. 2003;7:61-80
14. Tauman R, Montgomery-Downs HE, Ivanenko A, et al. Changes in sleep architecture and respiratory function following adenotonsillectomy in children with obstructive sleep apnea syndrome. Sleep. 2004(suppl);27:A100
15. Lim J, McKean M. Adenotonsillectomy for obstructive sleep apnoea in children. Cochrane Database Syst Rev. 2003;(1):CD003136
16. Marcus CL, Ward SL, Mallory GB, et al. Use of nasal continuous positive airway pressure as treatment of childhood obstructive sleep apnea. J Pediatr. 1995;127:88-94
17. O'Brien LM, Mervis CB, Holbrook CR, et al. Neurobehavioral implications of habitual snoring in children. Pediatrics. 2004;114:44-49
18. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr. 2001;138:838-844
19. Marcus CL. Nasal steroids as treatment for obstructive sleep apnea: don't throw away the scalpel yet. J Pediatr. 2001;138:795-797
20. Rubinstein I. Nasal inflammation is present in patients with obstructive sleep apnea. Laryngoscope. 1995;105:175-177
21. Sekosan M, Zakkar M, Wenig B, Olopade CO, Rubinstein I. Inflammation in the uvula mucosa with obstructive sleep apnea. Laryngoscope. 1996;106:1018-1020
22. Olopade CO, Christon JA, Zakkar M, et al. Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest. 1997;111:1500-1504
23. Boyd JH, Petrof BJ, Hamid Q, Fraser R, Kimoff RJ. Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med. 2004;170:541-546
24. Tauman R, Ivanenko A, O'Brien LM, Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics. 2004;113:564-569
25. Singulair [manufacturer prescribing information]. Whitehouse Station, NJ: Merck & Co, Inc; 1999
26. Becker A. Clinical evidence with montelukast in the management of chronic childhood asthma. Drugs. 2000;59(suppl 1):29-34, 43-45
27. Storms W, Michele TM, Knorr B, et al. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or =6 years. Clin Exp Allergy. 2001;31:77-87
28. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2-5 years. Pediatrics. 2001;108(3). Available at: www.pediatrics.org/cgi/ content/full/108/3/e48
29. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6-14 year old children: a randomized double blind trial. JAMA. 1998;279:1181-1186
30. Villaran C, O'Neill SJ, Helbling A, et al. Montelukast versus salmeterol in patients with asthma and exercise induced bronchoconstriction. J Allergy Clin Immunol. 1999;104:547-553
31. Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399:789-793
32. Heise CE, O'Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem. 2000;275:30531-30536
33. Goldbart AD, Goldman GL, Li RC, Brittian KR, Tauman R, Gozal D. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea and recurrent infection. Chest. 2004;126:13-18
34. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005;172:364-370
35. Goldbart AD, Veling MC, Goldman JL, Li RC, Brittian KR, Gozal D. Glucocorticoid receptor subunit expression in adenotonsillar tissue of children with obstructive sleep apnea. Pediatr Res. 2005;57:232-236
36. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subject. Washington, DC: National Institutes of Health; 1968. Publication No. 204
37. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med. 1996;153:866-878
38. Marcus CL, Omlin KJ, Basinki DJ, et al. Normal polysomnographic values for children and adolescents. Am Rev Respir Dis. 1992;156:1235-1239
39. EEG arousals: scoring and rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep. 1992;15:173-184
40. Tauman R, O'Brien LM, Holbrook CR, Gozal D. Sleep pressure score: a new index of sleep disruption in snoring children. Sleep. 2004;27:274-278
41. O'Brien LM, Tauman R, Gozal D. Sleep pressure correlates of cognitive and behavioral morbidity in snoring children. Sleep. 2004;27:279-282
42. Guilleminault C, Li KK, Khramtsov A, Pelayo R, Martinez S. Sleep disordered breathing: surgical outcomes in prepubertal children. Laryngoscope. 2004;114:132-137
43. Guilleminault C, Li K, Quo S, Inouye RN. A prospective study on the surgical outcomes of children with sleep-disordered breathing. Sleep. 2004;27:95-100
44. Waters KA, Everett FM, Bruderer JW, Sullivan CE. Obstructive sleep apnea: the use of nasal CPAP in 80 children. Am J Respir Crit Care Med. 1995;152:780-785
45. McNamara F, Sullivan CE. Treatment of obstructive sleep apnea syndrome in children. Sleep. 2000;23(suppl 4):S142-S146
46. Massa F, Gonsalez S, Laverty A, Wallis C, Lane R. The use of nasal continuous positive airway pressure to treat obstructive sleep apnoea. Arch Dis Child. 2002;87:438-443
47. Downey R 3rd, Perkin RM, MacQuarrie J. Nasal continuous positive airway pressure use in children with obstructive sleep apnea younger than 2 years of age. Chest. 2000;117:1608-1612
48. Palombini L, Pelayo R, Guilleminault C. Efficacy of automated continuous positive airway pressure in children with sleep-related breathing disorders in an attended setting. Pediatrics. 2004;113(5). Available at: www.pediatrics.org/cgi/content/full/113/5/e412
49. Hatipoglu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration. 2003;70:665-671
50. Gozal D, Burnside MM. Increased upper airway collapsibility in children with obstructive sleep apnea during wakefulness. Am J Respir Crit Care Med. 2004;169:163-167
51. Morton S, Rosen C, Larkin E, Tishler P, Aylor J, Redline S. Predictors of sleep-disordered breathing in children with a history of tonsillectomy and/or adenoidectomy. Sleep. 2001;24:823-829